1672 — Ascletis Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for Ascletis Pharma, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,714	2,501	2,482	2,299	1,946
Net Total Accounts Receivable
Net Total Receivables	48.2	67.4	29.3	19.7	0.152
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,830	2,632	2,545	2,333	1,971
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	84.6	77.9	73	68.5	57.2
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	3,067	2,830	2,657	2,491	2,125
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	73.8	91	108	141	153
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	85.4	101	117	149	158
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	2,982	2,729	2,540	2,342	1,966
Total Liabilities & Shareholders' Equity	3,067	2,830	2,657	2,491	2,125
Total Common Shares Outstanding